DEXAMETHASONE

DEXAMETHASONE was reported 299110 times

DEXAMETHASONE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 LYMPHOID TISSUE HYPOPLASIA 142 0.9281
1 THYMUS HYPOPLASIA 146 0.8391
2 PLASMA CELL LEUKAEMIA 324 0.5400
3 PLASMA CELL MYELOMA REFRACTORY 675 0.5045
4 RHINOCEREBRAL MUCORMYCOSIS 155 0.4467
5 PLASMA CELL MYELOMA RECURRENT 1360 0.4183
6 PLASMACYTOMA 741 0.3977
7 DISSEMINATED ASPERGILLOSIS 179 0.3792
8 PLASMA CELL MYELOMA 14408 0.3689
9 LIGHT CHAIN ANALYSIS INCREASED 350 0.3388
10 MONOCLONAL IMMUNOGLOBULIN PRESENT 240 0.3158
11 B-CELL TYPE ACUTE LEUKAEMIA 198 0.2698
12 DIFFUSE LARGE B-CELL LYMPHOMA REFRACTORY 250 0.2640
13 DIFFUSE LARGE B-CELL LYMPHOMA RECURRENT 541 0.2451
14 C-REACTIVE PROTEIN 215 0.2319
15 SECONDARY IMMUNODEFICIENCY 266 0.2189
16 PSEUDOMONAL SEPSIS 363 0.2071
17 CYTOMEGALOVIRUS CHORIORETINITIS 388 0.1988
18 PARAINFLUENZAE VIRUS INFECTION 302 0.1983
19 MYCOBACTERIUM CHELONAE INFECTION 146 0.1976
20 HYPOFIBRINOGENAEMIA 195 0.1966
21 OSTEOLYSIS 394 0.1926
22 DEEP VEIN THROMBOSIS POSTOPERATIVE 357 0.1782
23 NEUTROPENIC SEPSIS 1223 0.1711
24 NEUTROPENIC INFECTION 162 0.1693
25 ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT 433 0.1676
26 FEBRILE BONE MARROW APLASIA 710 0.1669
27 MUCORMYCOSIS 424 0.1630
28 STRONGYLOIDIASIS 246 0.1521
29 ESCHERICHIA BACTERAEMIA 348 0.1479
30 CARDIAC AMYLOIDOSIS 161 0.1462
31 CYTOPENIA 1773 0.1447
32 MULTIPLE MYELOMA 671 0.1438
33 STEM CELL TRANSPLANT 355 0.1419
34 FEBRILE INFECTION 166 0.1410
35 PNEUMONIA INFLUENZAL 167 0.1402
36 AUTONOMIC NEUROPATHY 142 0.1402
37 ACUTE LYMPHOCYTIC LEUKAEMIA 395 0.1394
38 LISTERIOSIS 154 0.1392
39 FEBRILE NEUTROPENIA 9210 0.1387
40 TUMOUR LYSIS SYNDROME 1221 0.1386
41 AMYLOIDOSIS 239 0.1385
42 PERIPHERAL MOTOR NEUROPATHY 188 0.1341
43 PERIPHERAL SENSORY NEUROPATHY 784 0.1340
44 ASPERGILLUS INFECTION 871 0.1326
45 BRONCHOPULMONARY ASPERGILLOSIS 1002 0.1291
46 CYTOMEGALOVIRUS INFECTION REACTIVATION 563 0.1273
47 ENTEROBACTER INFECTION 213 0.1266
48 STEROID DIABETES 187 0.1246
49 NEUTROPENIC COLITIS 252 0.1217
50 BONE LESION 432 0.1197
51 SYSTEMIC CANDIDA 300 0.1194
52 PNEUMONIA PNEUMOCOCCAL 172 0.1161
53 HUMAN HERPESVIRUS 6 INFECTION 219 0.1158
54 POLYNEUROPATHY 1384 0.1155
55 PERIPHERAL SENSORIMOTOR NEUROPATHY 141 0.1122
56 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 826 0.1100
57 ESCHERICHIA SEPSIS 318 0.1096
58 CYTOKINE RELEASE SYNDROME 2168 0.1080
59 APLASIA 207 0.1056
60 RHINOVIRUS INFECTION 411 0.1055
61 HEPATITIS B REACTIVATION 334 0.1051
62 MYELOPATHY 199 0.1047
63 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 619 0.1044
64 VENOOCCLUSIVE LIVER DISEASE 516 0.1044
65 SWOLLEN JOINT COUNT INCREASED 329 0.1031
66 THERAPY PARTIAL RESPONDER 1609 0.1030
67 PNEUMOCYSTIS JIROVECII PNEUMONIA 1034 0.1029
68 HYPOGAMMAGLOBULINAEMIA 676 0.1028
69 COVID-19 PNEUMONIA 1185 0.1003
70 X-RAY ABNORMAL 175 0.0978
71 DIFFUSE LARGE B-CELL LYMPHOMA 743 0.0963
72 THROMBOCYTOPENIA 10780 0.0963
73 ENDOPHTHALMITIS 578 0.0963
74 HAEMATOTOXICITY 913 0.0960
75 NEUROPATHY PERIPHERAL 8881 0.0933
76 JC VIRUS INFECTION 149 0.0931
77 OCULAR HYPERTENSION 179 0.0921
78 SUBSTANCE-INDUCED PSYCHOTIC DISORDER 206 0.0920
79 MUCOSAL INFLAMMATION 2390 0.0912
80 CLOSTRIDIUM DIFFICILE COLITIS 955 0.0900
81 CYTOMEGALOVIRUS VIRAEMIA 395 0.0887
82 STAPHYLOCOCCAL BACTERAEMIA 384 0.0883
83 PATHOLOGICAL FRACTURE 446 0.0878
84 PNEUMATOSIS INTESTINALIS 248 0.0869
85 NEUTROPENIA 11787 0.0866
86 BACTERIAL SEPSIS 281 0.0862
87 PNEUMONIA FUNGAL 339 0.0858
88 RHEUMATIC FEVER 381 0.0854
89 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 177 0.0853
90 PNEUMONIA CYTOMEGALOVIRAL 161 0.0828
91 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 789 0.0826
92 LYMPHOPENIA 1165 0.0823
93 BLOOD CULTURE POSITIVE 246 0.0821
94 CORNEAL OEDEMA 180 0.0802
95 ENTEROCOCCAL INFECTION 387 0.0800
96 PANCYTOPENIA 4453 0.0796
97 HYPERTRIGLYCERIDAEMIA 465 0.0794
98 APLASTIC ANAEMIA 414 0.0792
99 DIVERTICULAR PERFORATION 163 0.0791
100 BACTERAEMIA 924 0.0778
101 PNEUMONIA VIRAL 247 0.0774
102 MYELODYSPLASTIC SYNDROME 1120 0.0774
103 SEPTIC SHOCK 3308 0.0759
104 NEUTROPHIL COUNT ABNORMAL 213 0.0753
105 CUSHINGOID 241 0.0750
106 HISTIOCYTOSIS HAEMATOPHAGIC 221 0.0744
107 FULL BLOOD COUNT DECREASED 1484 0.0736
108 C-REACTIVE PROTEIN ABNORMAL 470 0.0732
109 STAPHYLOCOCCAL SEPSIS 357 0.0722
110 HYPERCALCAEMIA 891 0.0721
111 GASTROINTESTINAL TOXICITY 341 0.0709
112 SQUAMOUS CELL CARCINOMA OF SKIN 421 0.0697
113 FACET JOINT SYNDROME 227 0.0697
114 KLEBSIELLA INFECTION 349 0.0689
115 IMMUNE THROMBOCYTOPENIA 313 0.0683
116 NEUTROPHIL COUNT DECREASED 2780 0.0681
117 DUODENAL ULCER PERFORATION 502 0.0674
118 MULTIPLE ORGAN DYSFUNCTION SYNDROME 1904 0.0671
119 DISLOCATION OF VERTEBRA 153 0.0670
120 SPINAL CORD COMPRESSION 261 0.0670
121 BONE MARROW FAILURE 1362 0.0670
122 BRAIN ABSCESS 169 0.0667
123 RHEUMATOID FACTOR POSITIVE 384 0.0664
124 VENOUS THROMBOSIS 256 0.0652
125 LEUKOPENIA 3190 0.0637
126 DISEASE PROGRESSION 7527 0.0636
127 HYPOALBUMINAEMIA 492 0.0632
128 PSEUDOMONAS INFECTION 542 0.0631
129 METASTASES TO MENINGES 142 0.0624
130 NEUROTOXICITY 1093 0.0623
131 ENTERITIS 399 0.0623
132 EMBOLISM 513 0.0617
133 HICCUPS 507 0.0617
134 PROTEIN TOTAL INCREASED 162 0.0608
135 CYTOMEGALOVIRUS INFECTION 1004 0.0603
136 LEUKOENCEPHALOPATHY 221 0.0593
137 PARAPLEGIA 170 0.0588
138 NOCARDIOSIS 150 0.0586
139 LARGE INTESTINE PERFORATION 400 0.0575
140 ADENOVIRUS INFECTION 167 0.0575
141 CYSTITIS HAEMORRHAGIC 231 0.0572
142 VENOOCCLUSIVE DISEASE 143 0.0571
143 ATELECTASIS 546 0.0565
144 CANCER PAIN 144 0.0563
145 PLATELET COUNT DECREASED 5963 0.0559
146 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 148 0.0556
147 PERIPHERAL VENOUS DISEASE 227 0.0555
148 SEPSIS 6172 0.0553
149 ACUTE MYELOID LEUKAEMIA 862 0.0553
150 EMBOLISM VENOUS 167 0.0550
151 BONE MARROW DISORDER 166 0.0549
152 PNEUMONIA BACTERIAL 503 0.0547
153 ADRENAL INSUFFICIENCY 654 0.0538
154 CANDIDA INFECTION 908 0.0537
155 HYPOPHOSPHATAEMIA 397 0.0537
156 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 383 0.0534
157 THROMBOTIC MICROANGIOPATHY 520 0.0533
158 HYPERBILIRUBINAEMIA 552 0.0532
159 LUNG CONSOLIDATION 148 0.0529
160 HYPERTRANSAMINASAEMIA 367 0.0527
161 OESOPHAGEAL CANDIDIASIS 210 0.0526
162 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 432 0.0523
163 METASTASES TO CENTRAL NERVOUS SYSTEM 671 0.0520
164 ESCHERICHIA INFECTION 426 0.0517
165 VITREOUS HAEMORRHAGE 142 0.0513
166 ENTEROCOLITIS 296 0.0512
167 PSYCHOLOGICAL TRAUMA 440 0.0509
168 COMPRESSION FRACTURE 273 0.0509
169 SECOND PRIMARY MALIGNANCY 421 0.0506
170 HYPERGLYCAEMIA 1835 0.0503
171 ESCHERICHIA URINARY TRACT INFECTION 212 0.0498
172 LUNG INFILTRATION 440 0.0498
173 DEEP VEIN THROMBOSIS 3231 0.0497
174 BLOOD LACTATE DEHYDROGENASE INCREASED 783 0.0494
175 HYPOKALAEMIA 2277 0.0493
176 ILEUS PARALYTIC 220 0.0492
177 BRAIN HERNIATION 147 0.0492
178 VASCULAR DEVICE INFECTION 221 0.0487
179 BK VIRUS INFECTION 164 0.0486
180 BACTERIAL INFECTION 906 0.0485
181 NEOPLASM RECURRENCE 164 0.0483
182 HYPOXIA 1695 0.0481
183 ANAEMIA 9131 0.0478
184 ATRIAL FLUTTER 381 0.0477
185 ACUTE RESPIRATORY DISTRESS SYNDROME 844 0.0477
186 CARDIOTOXICITY 423 0.0474
187 BRAIN OEDEMA 598 0.0473
188 GUILLAIN-BARRE SYNDROME 229 0.0473
189 METASTASES TO SPINE 159 0.0473
190 HYPOCALCAEMIA 894 0.0472
191 PNEUMONITIS 1284 0.0471
192 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 180 0.0471
193 EPSTEIN-BARR VIRUS INFECTION 293 0.0469
194 PERFORMANCE STATUS DECREASED 218 0.0467
195 NECROTISING FASCIITIS 164 0.0465
196 SPINAL COMPRESSION FRACTURE 384 0.0464
197 INFUSION RELATED REACTION 3055 0.0460
198 THERAPY NON-RESPONDER 2069 0.0460
199 ENDOCARDITIS 236 0.0460
200 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 297 0.0457
201 ENCEPHALITIS 315 0.0455
202 RESPIRATORY TRACT INFECTION 1185 0.0455
203 ORAL CANDIDIASIS 596 0.0452
204 ACUTE RESPIRATORY FAILURE 870 0.0452
205 HEPATITIS B 271 0.0449
206 HYDROCEPHALUS 244 0.0447
207 GRAFT VERSUS HOST DISEASE 319 0.0443
208 PROTEIN TOTAL DECREASED 167 0.0443
209 FAILURE TO THRIVE 230 0.0443
210 LOW BIRTH WEIGHT BABY 351 0.0441
211 FOLLICULITIS 462 0.0440
212 THROMBOPHLEBITIS 154 0.0439
213 LEFT VENTRICULAR DYSFUNCTION 294 0.0438
214 HERPES SIMPLEX 285 0.0438
215 DISSEMINATED INTRAVASCULAR COAGULATION 614 0.0436
216 MYELOSUPPRESSION 1570 0.0435
217 WHITE BLOOD CELL COUNT DECREASED 4723 0.0435
218 RESPIRATORY FAILURE 3157 0.0432
219 POTENTIATING DRUG INTERACTION 145 0.0432
220 HYPERURICAEMIA 177 0.0430
221 ACUTE PULMONARY OEDEMA 241 0.0429
222 PNEUMONIA 13836 0.0427
223 LABORATORY TEST ABNORMAL 1261 0.0427
224 UROSEPSIS 388 0.0420
225 HAIR DISORDER 346 0.0419
226 HELICOBACTER INFECTION 430 0.0418
227 PULMONARY HAEMORRHAGE 327 0.0418
228 AUTOIMMUNE DISORDER 403 0.0413
229 PARADOXICAL DRUG REACTION 152 0.0413
230 CHRONIC GRAFT VERSUS HOST DISEASE 149 0.0412
231 INTRAOCULAR PRESSURE INCREASED 523 0.0409
232 RESPIRATORY SYNCYTIAL VIRUS INFECTION 353 0.0405
233 HEPATOTOXICITY 897 0.0402
234 HAEMOGLOBIN ABNORMAL 259 0.0402
235 LYMPHOCYTE COUNT DECREASED 710 0.0401
236 HAEMODYNAMIC INSTABILITY 306 0.0401
237 PULMONARY EMBOLISM 3811 0.0401
238 MUSCLE INJURY 332 0.0400
239 HYPOMAGNESAEMIA 556 0.0399
240 ILEUS 496 0.0399
241 MYOPATHY 341 0.0394
242 ELECTROLYTE IMBALANCE 457 0.0393
243 STOMATITIS 2385 0.0393
244 INTESTINAL PERFORATION 440 0.0392
245 LIP DRY 356 0.0392
246 LUNG INFECTION 608 0.0391
247 PLATELET COUNT ABNORMAL 236 0.0390
248 IMMUNOSUPPRESSION 339 0.0384
249 SKIN TOXICITY 217 0.0384
250 PLEURAL EFFUSION 2309 0.0379
251 INFECTION 5466 0.0377
252 TACHYPNOEA 513 0.0377
253 HYPOVOLAEMIA 220 0.0376
254 OSTEONECROSIS OF JAW 922 0.0372
255 ORGANISING PNEUMONIA 184 0.0371
256 PARTIAL SEIZURES 194 0.0370
257 STRESS CARDIOMYOPATHY 215 0.0369
258 ERYSIPELAS 185 0.0368
259 GASTROINTESTINAL PERFORATION 153 0.0368
260 HORDEOLUM 159 0.0367
261 ENCEPHALOPATHY 902 0.0367
262 DEVICE RELATED INFECTION 564 0.0366
263 HYPERVOLAEMIA 181 0.0366
264 LIVE BIRTH 305 0.0364
265 RESPIRATORY DISTRESS 1003 0.0363
266 MENINGITIS 242 0.0362
267 LOWER RESPIRATORY TRACT INFECTION 1643 0.0361
268 HYPERNATRAEMIA 179 0.0359
269 BLOOD ALBUMIN DECREASED 284 0.0358
270 WOUND INFECTION 392 0.0358
271 EJECTION FRACTION DECREASED 554 0.0356
272 POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER 181 0.0355
273 ANAPHYLACTIC SHOCK 910 0.0353
274 INTENTIONAL PRODUCT USE ISSUE 3088 0.0352
275 LUMBAR VERTEBRAL FRACTURE 161 0.0351
276 SERUM FERRITIN INCREASED 185 0.0350
277 CLOSTRIDIUM DIFFICILE INFECTION 764 0.0350
278 BASAL CELL CARCINOMA 546 0.0350
279 PULSELESS ELECTRICAL ACTIVITY 145 0.0347
280 CACHEXIA 178 0.0346
281 HAIR COLOUR CHANGES 428 0.0344
282 ATRIAL FIBRILLATION 3335 0.0342
283 MALIGNANT NEOPLASM PROGRESSION 3496 0.0341
284 BURSITIS 414 0.0341
285 TASTE DISORDER 692 0.0341
286 NEPHROPATHY TOXIC 382 0.0340
287 BRONCHOSPASM 485 0.0340
288 BLOOD MAGNESIUM DECREASED 293 0.0339
289 PEMPHIGUS 424 0.0339
290 NEOPLASM PROGRESSION 1176 0.0338
291 COLITIS 1267 0.0334
292 PHLEBITIS 171 0.0334
293 WHITE BLOOD CELL COUNT ABNORMAL 213 0.0333
294 MUSCULOSKELETAL CHEST PAIN 516 0.0333
295 RED BLOOD CELL COUNT DECREASED 949 0.0332
296 HUMERUS FRACTURE 160 0.0331
297 SYNOVITIS 597 0.0331
298 PERICARDITIS 553 0.0329
299 MADAROSIS 382 0.0329
300 BLOOD LACTIC ACID INCREASED 172 0.0326
301 ALANINE AMINOTRANSFERASE INCREASED 1997 0.0325
302 THROMBOSIS 2609 0.0324
303 OSTEONECROSIS 1064 0.0324
304 PARONYCHIA 142 0.0323
305 SCIATICA 515 0.0323
306 RASH MACULO-PAPULAR 718 0.0322
307 PYREXIA 11135 0.0321
308 CONSTIPATION 7018 0.0321
309 ACUTE KIDNEY INJURY 4909 0.0320
310 GINGIVITIS 173 0.0320
311 HAIR TEXTURE ABNORMAL 427 0.0319
312 HYPONATRAEMIA 1796 0.0319
313 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 327 0.0318
314 CELLULITIS 1603 0.0318
315 HAEMOGLOBIN DECREASED 3261 0.0317
316 FOETAL GROWTH RESTRICTION 193 0.0317
317 PULMONARY ALVEOLAR HAEMORRHAGE 178 0.0317
318 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 246 0.0316
319 SINUS TACHYCARDIA 449 0.0316
320 PULSE ABSENT 150 0.0315
321 DELIRIUM 1092 0.0314
322 WEIGHT FLUCTUATION 329 0.0314
323 NON-SMALL CELL LUNG CANCER 150 0.0313
324 OESOPHAGITIS 342 0.0313
325 NEUROLOGICAL SYMPTOM 177 0.0309
326 PETECHIAE 323 0.0309
327 ACUTE HEPATIC FAILURE 422 0.0309
328 GENERALISED OEDEMA 382 0.0308
329 PULMONARY THROMBOSIS 334 0.0306
330 HYDRONEPHROSIS 229 0.0306
331 DECUBITUS ULCER 249 0.0305
332 PNEUMOTHORAX 484 0.0305
333 ORAL PAIN 683 0.0305
334 ORTHOSTATIC HYPOTENSION 529 0.0303
335 CHOLECYSTITIS ACUTE 172 0.0303
336 PREMATURE DELIVERY 482 0.0302
337 HAND DEFORMITY 397 0.0302
338 PULMONARY TOXICITY 214 0.0302
339 STAPHYLOCOCCAL INFECTION 997 0.0302
340 HEMIPARESIS 512 0.0302
341 LYMPHOEDEMA 209 0.0302
342 ACUTE CORONARY SYNDROME 250 0.0302
343 NEOPLASM 345 0.0300
344 CEREBRAL ISCHAEMIA 154 0.0299
345 HAEMOLYTIC ANAEMIA 268 0.0299
346 ASCITES 879 0.0299
347 GENERAL PHYSICAL HEALTH DETERIORATION 3439 0.0297
348 UPPER RESPIRATORY TRACT INFECTION 1372 0.0297
349 ATAXIA 352 0.0296
350 C-REACTIVE PROTEIN INCREASED 1078 0.0296
351 LEUKOCYTOSIS 535 0.0295
352 BLOOD CALCIUM DECREASED 332 0.0295
353 INTRACRANIAL PRESSURE INCREASED 164 0.0294
354 CARDIAC FAILURE ACUTE 196 0.0294
355 HOSPICE CARE 290 0.0293
356 BONE DISORDER 534 0.0293
357 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 1608 0.0293
358 BLOOD POTASSIUM DECREASED 878 0.0292
359 DEHYDRATION 3882 0.0291
360 TOOTH DISORDER 641 0.0288
361 OEDEMA 1559 0.0287
362 LYMPHOMA 443 0.0286
363 SUPRAVENTRICULAR TACHYCARDIA 273 0.0285
364 ORAL DISORDER 209 0.0285
365 BLOOD BILIRUBIN INCREASED 770 0.0285
366 SUDDEN DEATH 300 0.0283
367 TRANSAMINASES INCREASED 628 0.0282
368 FLUID INTAKE REDUCED 141 0.0282
369 INTESTINAL ISCHAEMIA 154 0.0279
370 OSTEOMYELITIS 506 0.0279
371 TOXIC EPIDERMAL NECROLYSIS 424 0.0279
372 HAEMOLYSIS 215 0.0278
373 DRUG RESISTANCE 713 0.0277
374 TROPONIN INCREASED 211 0.0277
375 MENTAL STATUS CHANGES 768 0.0276
376 PYELONEPHRITIS 239 0.0276
377 ASPARTATE AMINOTRANSFERASE INCREASED 1455 0.0274
378 LIVER INJURY 672 0.0273
379 BLOOD CALCIUM INCREASED 240 0.0273
380 MALNUTRITION 306 0.0273
381 MULTI-ORGAN FAILURE 472 0.0273
382 PREMATURE BABY 821 0.0272
383 GRIP STRENGTH DECREASED 239 0.0271
384 CARDIAC FAILURE 2179 0.0271
385 BONE PAIN 1588 0.0271
386 AGEUSIA 675 0.0270
387 BLOOD CREATININE INCREASED 1765 0.0270
388 SINUS BRADYCARDIA 261 0.0270
389 STREPTOCOCCAL INFECTION 150 0.0269
390 CIRCULATORY COLLAPSE 459 0.0269
391 DECREASED APPETITE 6257 0.0269
392 BODY HEIGHT DECREASED 288 0.0269
393 RIB FRACTURE 553 0.0269
394 BREAST CANCER STAGE III 174 0.0268
395 DIARRHOEA 17335 0.0268
396 MULTIPLE ALLERGIES 210 0.0268
397 SQUAMOUS CELL CARCINOMA 252 0.0267
398 OLIGURIA 166 0.0267
399 BODY TEMPERATURE INCREASED 543 0.0266
400 MACULAR OEDEMA 149 0.0266
401 MOUTH ULCERATION 558 0.0265
402 BLOOD DISORDER 212 0.0264
403 HEPATOCELLULAR INJURY 375 0.0264
404 METASTASES TO BONE 433 0.0264
405 GLOSSODYNIA 590 0.0263
406 PULMONARY FIBROSIS 505 0.0263
407 OFF LABEL USE 22997 0.0262
408 SHOCK 604 0.0262
409 SPINAL OSTEOARTHRITIS 230 0.0262
410 GAMMA-GLUTAMYLTRANSFERASE INCREASED 580 0.0261
411 COAGULOPATHY 435 0.0261
412 SMALL INTESTINAL OBSTRUCTION 321 0.0261
413 CARDIOMYOPATHY 384 0.0260
414 LOWER LIMB FRACTURE 499 0.0259
415 AGRANULOCYTOSIS 481 0.0259
416 FLANK PAIN 242 0.0258
417 OXYGEN SATURATION DECREASED 1445 0.0257
418 RENAL IMPAIRMENT 2157 0.0256
419 GASTROENTERITIS 374 0.0256
420 HERPES ZOSTER 1472 0.0256
421 CATARACT 1519 0.0255
422 DERMATITIS ACNEIFORM 155 0.0254
423 RENAL FAILURE 3381 0.0254
424 OEDEMA PERIPHERAL 3099 0.0254
425 HYPOTENSION 5090 0.0253
426 PERICARDIAL EFFUSION 586 0.0253
427 HEPATOMEGALY 249 0.0253
428 PROTHROMBIN TIME PROLONGED 151 0.0252
429 ECCHYMOSIS 173 0.0252
430 NO THERAPEUTIC RESPONSE 307 0.0252
431 HYPOPHAGIA 643 0.0251
432 NIGHT SWEATS 809 0.0251
433 WOUND 701 0.0251
434 SPINAL FRACTURE 502 0.0250
435 NAIL DISORDER 219 0.0250
436 TOXIC SKIN ERUPTION 252 0.0250
437 PULMONARY OEDEMA 1120 0.0250
438 UNEVALUABLE EVENT 1892 0.0250
439 RED BLOOD CELL SEDIMENTATION RATE INCREASED 274 0.0247
440 COVID-19 4342 0.0247
441 DRUG INTOLERANCE 2381 0.0246
442 URINE OUTPUT DECREASED 215 0.0246
443 ANAPHYLACTIC REACTION 1351 0.0244
444 APPENDICITIS 228 0.0244
445 MYOSITIS 219 0.0244
446 TACHYCARDIA 2164 0.0243
447 HEPATIC FAILURE 733 0.0243
448 BLOOD ALKALINE PHOSPHATASE INCREASED 602 0.0242
449 GASTROINTESTINAL INFECTION 217 0.0242
450 RETINAL DETACHMENT 222 0.0241
451 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 620 0.0241
452 LIVER FUNCTION TEST INCREASED 515 0.0240
453 HAEMATOCRIT DECREASED 474 0.0239
454 SEASONAL ALLERGY 338 0.0239
455 MOUTH HAEMORRHAGE 175 0.0238
456 CHOLECYSTITIS 284 0.0238
457 LIVER DISORDER 1057 0.0238
458 ANURIA 205 0.0238
459 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 553 0.0237
460 ISCHAEMIC STROKE 423 0.0237
461 ASTHENIA 8886 0.0236
462 PANCREATITIS ACUTE 531 0.0236
463 PURPURA 209 0.0236
464 ACUTE MYOCARDIAL INFARCTION 695 0.0235
465 SPLENOMEGALY 276 0.0235
466 GASTROINTESTINAL INFLAMMATION 184 0.0235
467 ODYNOPHAGIA 140 0.0234
468 SKIN INFECTION 260 0.0232
469 DISEASE RECURRENCE 1096 0.0230
470 RETINAL HAEMORRHAGE 164 0.0230
471 NEURALGIA 557 0.0229
472 CORONAVIRUS INFECTION 151 0.0228
473 HEPATIC CYTOLYSIS 291 0.0228
474 SUBDURAL HAEMATOMA 325 0.0227
475 METASTASES TO LIVER 398 0.0226
476 LUNG DISORDER 1109 0.0226
477 FACIAL PARALYSIS 192 0.0225
478 FATIGUE 17534 0.0225
479 SARS-COV-2 TEST POSITIVE 297 0.0225
480 NEUTROPHIL COUNT INCREASED 230 0.0224
481 FUNGAL INFECTION 748 0.0224
482 TRANSFUSION 235 0.0224
483 COLITIS ISCHAEMIC 150 0.0222
484 SHOCK HAEMORRHAGIC 180 0.0221
485 TRICUSPID VALVE INCOMPETENCE 175 0.0220
486 PULMONARY MASS 328 0.0220
487 DIVERTICULITIS 609 0.0220
488 CONFUSIONAL STATE 3543 0.0219
489 UVEITIS 297 0.0219
490 STATUS EPILEPTICUS 247 0.0218
491 RENAL TUBULAR NECROSIS 214 0.0218
492 CYANOSIS 343 0.0218
493 EPISTAXIS 1629 0.0218
494 TOOTH ABSCESS 221 0.0217
495 JOINT RANGE OF MOTION DECREASED 291 0.0217
496 GENERAL PHYSICAL CONDITION ABNORMAL 147 0.0217
497 MITRAL VALVE INCOMPETENCE 245 0.0216
498 VIRAL INFECTION 719 0.0216
499 SPINAL PAIN 252 0.0215
500 IMPAIRED HEALING 706 0.0215
501 HAEMORRHAGE INTRACRANIAL 321 0.0214
502 IMMUNODEFICIENCY 320 0.0214
503 ORAL HERPES 419 0.0214
504 LYMPHADENOPATHY 755 0.0213
505 METASTASES TO LUNG 246 0.0213
506 LIPASE INCREASED 163 0.0213
507 BRADYCARDIA 1128 0.0212
508 MYOCLONUS 253 0.0212
509 PERIPHERAL SWELLING 3266 0.0212
510 RENAL FAILURE ACUTE 898 0.0211
511 HYPERKALAEMIA 740 0.0211
512 CARDIOGENIC SHOCK 302 0.0210
513 GENERALISED TONIC-CLONIC SEIZURE 348 0.0210
514 BLOOD UREA INCREASED 352 0.0210
515 GINGIVAL PAIN 167 0.0210
516 HEPATIC FUNCTION ABNORMAL 783 0.0210
517 DYSPNOEA EXERTIONAL 790 0.0210
518 HAEMOPTYSIS 583 0.0209
519 HYPERTHERMIA 159 0.0208
520 POLYURIA 170 0.0207
521 RESPIRATORY DISORDER 621 0.0207
522 URINARY TRACT INFECTION 3537 0.0207
523 EAR PAIN 403 0.0207
524 HYPERTENSIVE CRISIS 230 0.0207
525 SKIN ULCER 533 0.0206
526 APHASIA 621 0.0205
527 ACIDOSIS 157 0.0205
528 PLATELET COUNT INCREASED 267 0.0205
529 NERVOUS SYSTEM DISORDER 639 0.0205
530 UNRESPONSIVE TO STIMULI 528 0.0204
531 CARDIAC ARREST 1687 0.0204
532 BREAST CANCER METASTATIC 219 0.0204
533 PROTEINURIA 387 0.0203
534 BACK PAIN 4720 0.0203
535 CHOLESTASIS 389 0.0202
536 GASTROINTESTINAL DISORDER 1814 0.0202
537 TREATMENT FAILURE 1666 0.0201
538 TOOTH EXTRACTION 250 0.0201
539 SYNCOPE 2007 0.0200
540 IRRITABLE BOWEL SYNDROME 430 0.0200
541 VISUAL ACUITY REDUCED 666 0.0200
542 UPPER GASTROINTESTINAL HAEMORRHAGE 337 0.0200
543 TOXICITY TO VARIOUS AGENTS 3369 0.0200
544 DRUG-INDUCED LIVER INJURY 625 0.0199
545 CONTRAINDICATED PRODUCT ADMINISTERED 603 0.0199
546 INTERSTITIAL LUNG DISEASE 962 0.0198
547 PNEUMONIA ASPIRATION 493 0.0197
548 BRONCHITIS 1456 0.0197
549 FULL BLOOD COUNT ABNORMAL 208 0.0196
550 MYOCARDITIS 225 0.0196
551 MALIGNANT MELANOMA 263 0.0196
552 FIBROMYALGIA 477 0.0196
553 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 336 0.0196
554 HYPERAESTHESIA 161 0.0196
555 BRAIN NEOPLASM 180 0.0196
556 CHILLS 2286 0.0195
557 INCONTINENCE 206 0.0195
558 MASS 272 0.0194
559 EYE INFECTION 219 0.0194
560 EYE INFLAMMATION 183 0.0192
561 VENTRICULAR FIBRILLATION 213 0.0192
562 RASH 8352 0.0191
563 DRUG ERUPTION 339 0.0191
564 SPINAL DISORDER 181 0.0191
565 APHTHOUS ULCER 148 0.0191
566 HYPERCHOLESTEROLAEMIA 184 0.0190
567 HEPATIC ENZYME INCREASED 1298 0.0190
568 HAEMATURIA 652 0.0190
569 VOMITING 8927 0.0190
570 VENTRICULAR EXTRASYSTOLES 197 0.0190
571 SWELLING FACE 1229 0.0189
572 HEMIPLEGIA 157 0.0189
573 VASCULITIS 219 0.0188
574 ANAL INCONTINENCE 169 0.0188
575 GAIT INABILITY 626 0.0187
576 URINARY RETENTION 625 0.0187
577 GLAUCOMA 360 0.0187
578 CARDIO-RESPIRATORY ARREST 781 0.0187
579 BLOOD SODIUM DECREASED 352 0.0187
580 TENDERNESS 194 0.0186
581 RASH PRURITIC 1006 0.0185
582 GOUT 333 0.0185
583 DYSPHONIA 1082 0.0185
584 MYOCARDIAL ISCHAEMIA 210 0.0184
585 DYSPNOEA 10413 0.0184
586 OBESITY 293 0.0184
587 MUSCULAR WEAKNESS 2087 0.0183
588 HYPOAESTHESIA 2747 0.0183
589 PERITONITIS 380 0.0183
590 BLOOD COUNT ABNORMAL 278 0.0183
591 PRODUCTIVE COUGH 875 0.0183
592 CARDIOMEGALY 225 0.0183
593 TOOTH INFECTION 241 0.0183
594 HEPATIC ENCEPHALOPATHY 170 0.0182
595 BLOOD TEST ABNORMAL 254 0.0181
596 PRODUCT USE IN UNAPPROVED INDICATION 4470 0.0180
597 NAUSEA 14244 0.0180
598 INFLUENZA 2000 0.0179
599 SUBARACHNOID HAEMORRHAGE 182 0.0179
600 EXOSTOSIS 163 0.0178
601 LETHARGY 1023 0.0178
602 RENAL DISORDER 828 0.0178
603 HEPATITIS 454 0.0177
604 LIVER FUNCTION TEST ABNORMAL 516 0.0177
605 CEREBRAL INFARCTION 432 0.0177
606 WHITE BLOOD CELL COUNT INCREASED 676 0.0176
607 SKIN LESION 483 0.0176
608 METABOLIC ACIDOSIS 562 0.0176
609 RESPIRATORY RATE INCREASED 156 0.0176
610 INFLAMMATION 905 0.0175
611 HEPATIC STEATOSIS 326 0.0175
612 FACE OEDEMA 294 0.0174
613 MUSCLE SPASMS 3192 0.0174
614 ARTHROPATHY 966 0.0174
615 ADVERSE DRUG REACTION 1557 0.0173
616 OSTEOPENIA 263 0.0173
617 DERMATITIS ALLERGIC 218 0.0173
618 COGNITIVE DISORDER 809 0.0173
619 IMPAIRED QUALITY OF LIFE 249 0.0173
620 PAIN IN JAW 490 0.0173
621 INCREASED TENDENCY TO BRUISE 159 0.0173
622 ALOPECIA 3390 0.0172
623 CEREBRAL HAEMORRHAGE 617 0.0172
624 ABDOMINAL PAIN 4006 0.0172
625 OSTEOARTHRITIS 730 0.0172
626 HYPERTENSION 3640 0.0172
627 FLUID OVERLOAD 249 0.0171
628 TYPE 2 DIABETES MELLITUS 576 0.0171
629 HAEMORRHOIDS 333 0.0171
630 PARAESTHESIA 2683 0.0170
631 CONJUNCTIVITIS 316 0.0170
632 DIARRHOEA HAEMORRHAGIC 159 0.0170
633 IMMUNE SYSTEM DISORDER 224 0.0170
634 BLISTER 954 0.0170
635 DYSGEUSIA 1260 0.0169
636 STEVENS-JOHNSON SYNDROME 377 0.0169
637 URINARY INCONTINENCE 500 0.0169
638 TOOTHACHE 304 0.0168
639 SWOLLEN TONGUE 524 0.0168
640 PROSTATIC SPECIFIC ANTIGEN INCREASED 231 0.0168
641 WHEEZING 992 0.0167
642 CONTUSION 1607 0.0167
643 PHARYNGITIS 207 0.0167
644 DISORIENTATION 660 0.0166
645 DYSPHAGIA 1571 0.0165
646 GROIN PAIN 145 0.0165
647 FLUSHING 1676 0.0165
648 GINGIVAL BLEEDING 225 0.0165
649 INTERVERTEBRAL DISC DEGENERATION 152 0.0164
650 HYPERLIPIDAEMIA 195 0.0163
651 WEIGHT DECREASED 4553 0.0163
652 VENTRICULAR TACHYCARDIA 269 0.0163
653 JAUNDICE 438 0.0163
654 VITREOUS FLOATERS 160 0.0163
655 MUSCULOSKELETAL PAIN 852 0.0162
656 ALTERED STATE OF CONSCIOUSNESS 352 0.0162
657 PERIPHERAL COLDNESS 223 0.0162
658 DYSARTHRIA 611 0.0162
659 SINUSITIS 1661 0.0162
660 OROPHARYNGEAL DISCOMFORT 146 0.0161
661 LACRIMATION INCREASED 488 0.0161
662 LOCALISED INFECTION 390 0.0161
663 HYPERTHYROIDISM 233 0.0161
664 PULMONARY HYPERTENSION 335 0.0161
665 CYSTITIS 510 0.0160
666 MELAENA 352 0.0160
667 ABSCESS 255 0.0160
668 BLOOD CHOLESTEROL INCREASED 745 0.0160
669 HYPOTONIA 159 0.0159
670 ASPIRATION 174 0.0159
671 FLUID RETENTION 803 0.0158
672 GASTRITIS 414 0.0157
673 DEATH 13551 0.0157
674 PULMONARY CONGESTION 207 0.0157
675 BLOOD IRON DECREASED 185 0.0156
676 RECTAL HAEMORRHAGE 666 0.0155
677 CENTRAL NERVOUS SYSTEM LESION 213 0.0155
678 HYPERSENSITIVITY 2877 0.0155
679 PATHOGEN RESISTANCE 141 0.0155
680 DRUG TOXICITY 209 0.0153
681 EPILEPSY 468 0.0153
682 GASTROINTESTINAL HAEMORRHAGE 1278 0.0153
683 LEUKAEMIA 144 0.0152
684 PANCREATITIS 803 0.0152
685 HIP FRACTURE 488 0.0152
686 CHEST DISCOMFORT 1548 0.0151
687 DISCOMFORT 922 0.0151
688 NERVE INJURY 168 0.0151
689 PRESYNCOPE 367 0.0151
690 COUGH 4216 0.0150
691 DYSPEPSIA 1476 0.0150
692 CARDIAC FAILURE CONGESTIVE 1204 0.0150
693 CHEST PAIN 2771 0.0149
694 ELECTROCARDIOGRAM QT PROLONGED 535 0.0149
695 BLOOD PRESSURE DECREASED 988 0.0149
696 BODY TEMPERATURE DECREASED 146 0.0148
697 ARRHYTHMIA 702 0.0148
698 ANGIOEDEMA 655 0.0148
699 JOINT SWELLING 1777 0.0147
700 DEPRESSED LEVEL OF CONSCIOUSNESS 582 0.0147
701 MUSCLE ATROPHY 186 0.0147
702 MANIA 241 0.0146
703 SWELLING 1370 0.0146
704 PRESCRIBED UNDERDOSE 291 0.0146
705 PARAESTHESIA ORAL 209 0.0145
706 TREMOR 2390 0.0144
707 BLINDNESS 584 0.0143
708 EYELID PTOSIS 145 0.0143
709 DRUG INTERACTION 2262 0.0142
710 BACK DISORDER 231 0.0142
711 FOETAL EXPOSURE DURING PREGNANCY 1150 0.0141
712 PRESCRIBED OVERDOSE 273 0.0141
713 DENTAL CARIES 156 0.0141
714 DRY MOUTH 1144 0.0141
715 GLOMERULAR FILTRATION RATE DECREASED 173 0.0141
716 RASH GENERALISED 364 0.0140
717 DYSURIA 516 0.0140
718 EXPOSURE DURING PREGNANCY 870 0.0140
719 GASTRIC ULCER 266 0.0140
720 INSOMNIA 3716 0.0139
721 SEIZURE 1604 0.0139
722 HIP ARTHROPLASTY 212 0.0138
723 NASOPHARYNGITIS 2542 0.0138
724 HAEMATEMESIS 349 0.0138
725 MATERNAL EXPOSURE DURING PREGNANCY 1223 0.0137
726 BRAIN FOG 215 0.0137
727 TUBULOINTERSTITIAL NEPHRITIS 257 0.0137
728 TRANSIENT ISCHAEMIC ATTACK 462 0.0137
729 EATING DISORDER 291 0.0137
730 BALANCE DISORDER 1180 0.0136
731 DEAFNESS 356 0.0136
732 PALLOR 370 0.0136
733 HYPOAESTHESIA ORAL 204 0.0135
734 THERAPEUTIC RESPONSE DECREASED 818 0.0135
735 REBOUND EFFECT 152 0.0134
736 THROAT TIGHTNESS 363 0.0134
737 CONDITION AGGRAVATED 4072 0.0134
738 ULCER 213 0.0134
739 FALL 4451 0.0134
740 ABDOMINAL DISTENSION 1395 0.0134
741 SKIN LACERATION 145 0.0133
742 SYSTEMIC LUPUS ERYTHEMATOSUS 473 0.0133
743 PSYCHOMOTOR HYPERACTIVITY 221 0.0133
744 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 694 0.0133
745 SKIN REACTION 187 0.0133
746 PARALYSIS 190 0.0133
747 INTERVERTEBRAL DISC PROTRUSION 290 0.0133
748 INCREASED APPETITE 253 0.0132
749 LIMB DISCOMFORT 409 0.0132
750 THERAPEUTIC PRODUCT EFFECT DECREASED 592 0.0132
751 RHINORRHOEA 854 0.0132
752 OSTEOPOROSIS 541 0.0131
753 INTESTINAL OBSTRUCTION 494 0.0131
754 SKIN DISCOLOURATION 601 0.0131
755 BLOOD PRESSURE ABNORMAL 260 0.0131
756 FEELING HOT 799 0.0130
757 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 927 0.0130
758 FEEDING DISORDER 264 0.0130
759 EAR INFECTION 346 0.0130
760 HYPERSOMNIA 371 0.0129
761 MOBILITY DECREASED 926 0.0129
762 DERMATITIS 269 0.0128
763 PRODUCT USE ISSUE 2398 0.0127
764 ERYTHEMA 2609 0.0127
765 BLOOD POTASSIUM INCREASED 206 0.0127
766 ANGINA PECTORIS 363 0.0127
767 HAEMATOMA 328 0.0126
768 VISION BLURRED 1711 0.0124
769 OROPHARYNGEAL PAIN 1148 0.0124
770 INTERNATIONAL NORMALISED RATIO INCREASED 353 0.0124
771 MUSCLE TWITCHING 285 0.0124
772 HYPOTHYROIDISM 394 0.0123
773 END STAGE RENAL DISEASE 225 0.0123
774 SKIN DISORDER 411 0.0123
775 ABDOMINAL PAIN UPPER 2533 0.0123
776 SINUS DISORDER 243 0.0123
777 JOINT INJURY 262 0.0123
778 DIABETES MELLITUS 929 0.0122
779 GASTRIC HAEMORRHAGE 140 0.0122
780 HAEMORRHAGE 1267 0.0121
781 RASH ERYTHEMATOUS 579 0.0121
782 RESTLESSNESS 442 0.0121
783 HEART RATE DECREASED 424 0.0121
784 BLOOD PRESSURE SYSTOLIC INCREASED 235 0.0120
785 SLEEP DISORDER 848 0.0120
786 EOSINOPHILIA 210 0.0120
787 PHOTOPHOBIA 225 0.0120
788 DIPLOPIA 310 0.0119
789 NECK PAIN 660 0.0118
790 DIABETIC KETOACIDOSIS 283 0.0118
791 FEELING JITTERY 224 0.0117
792 FRACTURE 222 0.0117
793 GASTROOESOPHAGEAL REFLUX DISEASE 943 0.0117
794 EYE DISORDER 385 0.0117
795 POOR QUALITY SLEEP 251 0.0116
796 DEMENTIA 323 0.0115
797 UPPER LIMB FRACTURE 230 0.0115
798 CHOLELITHIASIS 378 0.0115
799 ABDOMINAL DISCOMFORT 1932 0.0115
800 CHROMATURIA 260 0.0115
801 CARDIAC DISORDER 1074 0.0115
802 QUALITY OF LIFE DECREASED 154 0.0115
803 ADVERSE EVENT 1054 0.0114
804 AGITATION 839 0.0114
805 BLINDNESS UNILATERAL 161 0.0114
806 LOSS OF CONSCIOUSNESS 1461 0.0114
807 DIZZINESS 5670 0.0114
808 ROAD TRAFFIC ACCIDENT 473 0.0113
809 MALAISE 4955 0.0113
810 HYPERHIDROSIS 1446 0.0112
811 COLON CANCER 167 0.0112
812 WEIGHT INCREASED 2504 0.0112
813 RASH MACULAR 388 0.0111
814 EYE HAEMORRHAGE 148 0.0111
815 HEART RATE INCREASED 1096 0.0111
816 FEMUR FRACTURE 342 0.0110
817 MUSCULOSKELETAL STIFFNESS 963 0.0110
818 AMNESIA 715 0.0110
819 PREGNANCY 219 0.0109
820 PAIN IN EXTREMITY 3207 0.0109
821 PRODUCT PRESCRIBING ISSUE 237 0.0109
822 PSYCHOTIC DISORDER 321 0.0109
823 GALLBLADDER DISORDER 194 0.0109
824 ILL-DEFINED DISORDER 659 0.0108
825 COLD SWEAT 191 0.0108
826 RESPIRATORY TRACT CONGESTION 172 0.0108
827 EYE PAIN 610 0.0108
828 HEPATIC CIRRHOSIS 203 0.0108
829 BLOOD PRESSURE INCREASED 1631 0.0107
830 PSORIATIC ARTHROPATHY 432 0.0106
831 BLOOD GLUCOSE ABNORMAL 196 0.0106
832 FLATULENCE 601 0.0106
833 CARDIOVASCULAR DISORDER 269 0.0106
834 SINUS CONGESTION 143 0.0106
835 GASTROENTERITIS VIRAL 191 0.0106
836 VERTIGO 641 0.0105
837 TINNITUS 482 0.0105
838 THIRST 187 0.0105
839 SOMNOLENCE 2107 0.0105
840 APHONIA 146 0.0105
841 VISUAL IMPAIRMENT 1296 0.0104
842 MEMORY IMPAIRMENT 1424 0.0104
843 RETCHING 220 0.0103
844 FEELING COLD 286 0.0103
845 INJURY 720 0.0102
846 COMPLICATION OF DEVICE INSERTION 203 0.0102
847 GAIT DISTURBANCE 1950 0.0102
848 DRUG INEFFECTIVE 13373 0.0101
849 SPEECH DISORDER 531 0.0101
850 POLLAKIURIA 422 0.0101
851 URTICARIA 1693 0.0101
852 DRUG LEVEL INCREASED 167 0.0101
853 DRY EYE 501 0.0100
854 BLOOD TRIGLYCERIDES INCREASED 175 0.0099
855 PRURITUS 3803 0.0099
856 KIDNEY INFECTION 194 0.0099
857 OCULAR HYPERAEMIA 467 0.0098
858 NEPHROLITHIASIS 449 0.0098
859 SEROTONIN SYNDROME 188 0.0098
860 CONVULSION 557 0.0097
861 BLOOD URINE PRESENT 184 0.0097
862 CEREBROVASCULAR ACCIDENT 1623 0.0096
863 LIMB INJURY 260 0.0096
864 GASTRIC DISORDER 328 0.0095
865 JOINT STIFFNESS 249 0.0095
866 COMA 451 0.0095
867 HYPOGLYCAEMIA 459 0.0095
868 HAEMATOCHEZIA 519 0.0094
869 HEADACHE 5876 0.0094
870 KNEE ARTHROPLASTY 197 0.0093
871 ANXIETY 2651 0.0093
872 MUSCULOSKELETAL DISORDER 177 0.0093
873 LACTIC ACIDOSIS 301 0.0093
874 PAIN 5698 0.0093
875 CHRONIC KIDNEY DISEASE 704 0.0093
876 MYALGIA 1573 0.0092
877 SKIN FISSURES 180 0.0092
878 HEART RATE IRREGULAR 208 0.0092
879 PELVIC PAIN 167 0.0092
880 ARTHRALGIA 3787 0.0091
881 PRODUCT DOSE OMISSION 593 0.0091
882 SKIN EXFOLIATION 761 0.0090
883 LUNG NEOPLASM MALIGNANT 370 0.0090
884 RESPIRATORY ARREST 248 0.0090
885 HYPOACUSIS 386 0.0090
886 MUSCULOSKELETAL DISCOMFORT 154 0.0089
887 PHOTOSENSITIVITY REACTION 147 0.0089
888 BLOOD PRESSURE FLUCTUATION 213 0.0089
889 ARTHRITIS 689 0.0088
890 FAECES DISCOLOURED 189 0.0087
891 ASTHMA 985 0.0087
892 SKIN CANCER 187 0.0087
893 LOCAL SWELLING 151 0.0086
894 EYE SWELLING 321 0.0086
895 DYSSTASIA 250 0.0086
896 DRY SKIN 1135 0.0085
897 DIABETES MELLITUS INADEQUATE CONTROL 150 0.0085
898 RHABDOMYOLYSIS 353 0.0085
899 MEDICATION ERROR 468 0.0084
900 THERAPY INTERRUPTED 601 0.0084
901 HEAD INJURY 263 0.0083
902 TOOTH LOSS 172 0.0083
903 NASAL CONGESTION 486 0.0083
904 BLOOD GLUCOSE INCREASED 1549 0.0082
905 RASH PAPULAR 184 0.0082
906 ABDOMINAL PAIN LOWER 206 0.0081
907 RESTLESS LEGS SYNDROME 148 0.0081
908 CORONARY ARTERY DISEASE 245 0.0081
909 THROAT IRRITATION 363 0.0081
910 TREATMENT NONCOMPLIANCE 442 0.0081
911 POST PROCEDURAL COMPLICATION 155 0.0081
912 FOOT FRACTURE 153 0.0081
913 HEAD DISCOMFORT 142 0.0080
914 DISTURBANCE IN ATTENTION 432 0.0080
915 BLOOD CREATINE PHOSPHOKINASE INCREASED 228 0.0079
916 DISABILITY 156 0.0079
917 HALLUCINATION 594 0.0079
918 LIP SWELLING 261 0.0078
919 DEPRESSION 1782 0.0078
920 DEPRESSED MOOD 414 0.0078
921 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 375 0.0078
922 MENTAL IMPAIRMENT 188 0.0077
923 HERNIA 149 0.0077
924 HOT FLUSH 579 0.0077
925 IRRITABILITY 461 0.0077
926 NERVOUSNESS 397 0.0076
927 SLEEP APNOEA SYNDROME 145 0.0076
928 ILLNESS 780 0.0076
929 NEOPLASM MALIGNANT 503 0.0075
930 ERUCTATION 145 0.0075
931 MYOCARDIAL INFARCTION 1301 0.0075
932 PALPITATIONS 867 0.0074
933 FEELING ABNORMAL 1743 0.0073
934 BURNING SENSATION 499 0.0071
935 ABASIA 174 0.0070
936 RENAL INJURY 208 0.0070
937 MOVEMENT DISORDER 224 0.0070
938 DEVICE DISLOCATION 303 0.0070
939 HALLUCINATION, VISUAL 146 0.0069
940 SNEEZING 154 0.0069
941 MOOD ALTERED 187 0.0068
942 MIGRAINE 654 0.0068
943 ANHEDONIA 178 0.0068
944 INFLUENZA LIKE ILLNESS 549 0.0067
945 FREQUENT BOWEL MOVEMENTS 180 0.0067
946 HOSPITALISATION 998 0.0065
947 DYSKINESIA 257 0.0063
948 AGGRESSION 313 0.0062
949 MENTAL DISORDER 272 0.0062
950 ABNORMAL BEHAVIOUR 246 0.0062
951 RHEUMATOID ARTHRITIS 702 0.0062
952 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 180 0.0061
953 PRODUCT DOSE OMISSION ISSUE 1791 0.0061
954 MOOD SWINGS 190 0.0060
955 INTENTIONAL DOSE OMISSION 168 0.0059
956 SEDATION 154 0.0059
957 THERAPY CESSATION 294 0.0057
958 NO ADVERSE EVENT 1001 0.0055
959 EYE PRURITUS 181 0.0054
960 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 965 0.0053
961 DRUG EFFECT INCOMPLETE 193 0.0053
962 PRODUCT DOSE OMISSION IN ERROR 150 0.0053
963 PROSTATE CANCER 423 0.0053
964 BREAST CANCER 485 0.0052
965 EMOTIONAL DISTRESS 586 0.0048
966 EMOTIONAL DISORDER 145 0.0047
967 DRUG DOSE OMISSION 759 0.0046
968 PANIC ATTACK 162 0.0044
969 ACCIDENTAL OVERDOSE 161 0.0044
970 INTENTIONAL PRODUCT MISUSE 366 0.0042
971 BLOOD GLUCOSE DECREASED 200 0.0042
972 UNDERDOSE 280 0.0038
973 VAGINAL HAEMORRHAGE 163 0.0038
974 ECZEMA 194 0.0037
975 EYE IRRITATION 202 0.0035
976 THERAPEUTIC RESPONSE UNEXPECTED 147 0.0033
977 ACNE 236 0.0031
978 SURGERY 178 0.0030
979 DRUG EFFECT DECREASED 150 0.0028
980 INJECTION SITE REACTION 186 0.0027
981 OVERDOSE 557 0.0026
982 SUICIDAL IDEATION 217 0.0024
983 DEVICE MALFUNCTION 145 0.0021
984 SKIN BURNING SENSATION 145 0.0020
985 DRUG ABUSE 164 0.0020
986 INCORRECT DOSE ADMINISTERED 445 0.0019
987 PSORIASIS 246 0.0019
988 PRODUCT QUALITY ISSUE 225 0.0017
989 INJECTION SITE ERYTHEMA 205 0.0017
990 DRUG DEPENDENCE 258 0.0016
991 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 259 0.0013
992 INJECTION SITE PAIN 363 0.0012